Advertisement

Navigating Bronchiectasis Care: Clinical Insights and Evolving Treatment Approaches - Episode 11

Airway Clearance Strategies for Bronchiectasis Patients

Published on: 
, , ,

Airway clearance delivers meaningful benefit only when patients actually use it consistently, making education and treatment-burden awareness as important as the devices themselves.

In "Airway Clearance Strategies for Bronchiectasis Patients," the panel explores how to build an airway clearance regimen patients will actually sustain.

Dr. Basavaraj asks Dr. ElMaraachli how he approaches airway clearance now that the CHEST guidelines offer specific recommendations for interventions such as positive pressure devices, high-frequency chest wall oscillation, and hypertonic saline. Dr. ElMaraachli explains that a dedicated respiratory therapist session, separate from discussions of antibiotics or anti-inflammatory therapy, is essential for proper education. His most common prescription pairs nebulized hypertonic saline with a positive expiratory pressure device, supplemented with instructional videos and regular respiratory therapist check-ins to confirm patients are using the equipment correctly. High-frequency chest wall oscillation becomes an add-on option for patients needing more aggressive clearance or still exacerbating despite hypertonic saline.

Dr. ElMaraachli emphasizes that these therapies carry real treatment burden. Sessions can last ten to twenty-five minutes, equipment accumulates as clutter in patients' homes, and devices require ongoing maintenance and cleaning. While data show these treatments improve quality of life, he notes that the burden itself remains a meaningful downside that clinicians should acknowledge rather than dismiss.

Dr. Metersky agrees, adding that no single clearance modality has been shown superior to others in the evidence base. The best modality, he says, is ultimately whichever one the patient will actually use consistently, since a device left unused in a closet provides no benefit regardless of its theoretical efficacy.

Dr. Khabbaza builds on this, explaining that patient education transforms adherence. Patients once labeled as noncompliant often become highly consistent once they understand how airway clearance connects to the vicious vortex and reduces their need for antibiotics. He describes starting with more aggressive regimens during symptomatic periods, then stepping down when patients stabilize, giving them an action plan to escalate again if symptoms worsen. Dr. Basavaraj adds that reviewing CT scan improvements with patients over time reinforces motivation to continue clearance therapy.

In "Inhaled Antibiotics for Pseudomonas in Bronchiectasis," the panel will address how to sequence inhaled antibiotics for patients colonized with pseudomonas.

Advertisement
Advertisement